Jurmeister, P., Weber, K., Villegas, S., Karn, T., Untch, M., Thieme, A., . . . Capper, D. (2021). DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status. Clinical epigenetics, 13, . https://doi.org/10.1186/s13148-021-01176-5
Chicago-Zitierstil (17. Ausg.)Jurmeister, Philipp, et al. "DNA Methylation Profiling Identifies Two Distinct Subgroups in Breast Cancers with Low Hormone Receptor Expression, Mainly Associated with HER2 Amplification Status." Clinical Epigenetics 13 (2021). https://doi.org/10.1186/s13148-021-01176-5.
MLA-Zitierstil (9. Ausg.)Jurmeister, Philipp, et al. "DNA Methylation Profiling Identifies Two Distinct Subgroups in Breast Cancers with Low Hormone Receptor Expression, Mainly Associated with HER2 Amplification Status." Clinical Epigenetics, vol. 13, 2021, https://doi.org/10.1186/s13148-021-01176-5.